FDA Clearance Tracker · P020045-S095
Freezor Cardiac Cryoablation System
Last checked: Nov 20, 2026Latest source record: Oct 12, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Oct 12, 2021
Approved
Time to decision
229 days
Received Feb 25, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P020045-S095
- Device name
- Freezor Cardiac Cryoablation System
- Applicant
- Medtronic Cryocath, LP
- Applicant location
- Mounds View, MN
- Received
- Feb 25, 2021
- Decided
- Oct 12, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P020045
Device type
- Device type
- Cardiac ablation percutaneous catheter (LPB)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for an alternate packaging site; a new sterilization method and site; and packaging improvements for the electrical umbilical.
Source documents
Other decisions for Medtronic Cryocath, LP
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P100010-S110 · Decided Jun 18, 2021 · 231 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
K202620 · Decided Nov 13, 2020 · 64 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
- Arctic Front Advance, Arctic Front Advance Pro and Freezor MAX Cardiac Cryoablation CathetersPMA supplement
P100010-S098 · Decided Jun 23, 2020 · 242 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.